Vinorelbine Tartrate

Vinorelbine Tartrate

6.2 Moderate risk

Vinorelbine Tartrate & Myelosuppression

52.9%

of users reported Myelosuppression

77.8%

also reported Hospitalization

63.0%

are men

Most common medical consequences

Hospitalization
77.8%
Severe reaction
22.2%

Have you experienced any negative side effects from this medication?

Vinorelbine Tartrate: general information

Most common side effects (3)

Most commonly affected ages

50 - 59 years
84.1%
60 - 69 years
15.9%